Lenz Therapeutics
(NASDAQ) LENZ
Lenz Therapeutics Financials at a Glance
Market Cap
$284.38M
Revenue (TTM)
$19.09M
Net Income (TTM)
$82.13M
EPS (TTM)
$-2.80
P/E Ratio
-3.24
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$9.08
Volume
15,830
Open
$9.25
Price
$9.08
Volume
15,830
Open
$9.25
Previous Close
$9.08
Daily Range
$8.99 - $9.30
52-Week Range
$8.25 - $50.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$9.08
Volume
15,830
Open
$9.25
Previous Close
$9.08
Daily Range
$8.99 - $9.30
52-Week Range
$8.25 - $50.40
LENZ News
LENZ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lenz Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
152
CEO
Evert B. Schimmelpennink
Website
www.lenz-tx.comHeadquarters
Solana Beach, CA 92014, US
LENZ Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-34%
Return on Capital
-32%
Return on Assets
-27%
Earnings Yield
-30.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$284.38M
Shares Outstanding
31.35M
Volume
15.83K
Short Interest
0.00%
Avg. Volume
1.04M
Financials (TTM)
Gross Profit
$18.67M
Operating Income
$91.14M
EBITDA
$91.14M
Operating Cash Flow
$69.17M
Capital Expenditure
$827.00K
Free Cash Flow
$70.00M
Cash & ST Invst.
$292.35M
Total Debt
$350.00K
Lenz Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.59M
N/A
Gross Profit
$1.17M
N/A
Gross Margin
73.68%
N/A
Market Cap
$284.38M
N/A
Market Cap/Employee
$47.40M
N/A
Employees
6
N/A
Net Income
$35.90M
-183.7%
EBITDA
$38.46M
-153.0%
Quarterly Fundamentals
Net Cash
$292.00M
+40.6%
Accounts Receivable
$2.43M
N/A
Inventory
$0.00
N/A
Long Term Debt
$350.00K
-57.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-26.85%
N/A
Return on Invested Capital
-32.01%
N/A
Free Cash Flow
$33.06M
-258.3%
Operating Cash Flow
$33.02M
-263.8%